<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000615324"><TermName>vincristine sulfate</TermName><TermPronunciation>(vin-KRIS-teen SUL-fayt)</TermPronunciation><TermDefinition><DefinitionText>A drug used to treat acute leukemia. It is used in combination with other drugs to treat Hodgkin disease, non-Hodgkin lymphoma, rhabdomyosarcoma, neuroblastoma, and Wilms tumor. Vincristine sulfate is also being studied in the treatment of other types of cancer. It blocks cell growth by stopping cell division. It is a type of vinca alkaloid and a type of antimitotic agent. Also called Oncovin.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000720803" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;vincristine sulfate&quot;" language="en" id="_3"/><MediaLink ref="CDR0000720802" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;sulfato de vincristina&quot;" language="es" id="_4"/><SpanishTermName>sulfato de vincristina</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para tratar la leucemia aguda. Se usa en combinación con otros medicamentos para tratar la enfermedad de Hodgkin, el linfoma no Hodgkin, el rabdomiosarcoma, el neuroblastoma y el tumor de Wilms. Asimismo, el sulfato de vincristina está en estudio para el tratamiento de otros tipos de cáncer. Bloquea la formación de células al impedir su multiplicación. Es un tipo de alcaloide de vinca y un tipo de antimitótico. También se llama Oncovin.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2008-09-19</DateFirstPublished><RelatedInformation><RelatedDrugSummaryRef href="CDR0000599877">Vincristine Sulfate</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
